HERMES PHARMA LIMITED
Significant control: Zulfiqar Ali Khan (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Hermes Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Hermes Pharma Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
HERMES PHARMA LIMITED is an active private limited company (company number 11198191) incorporated on 9 February 2018, registered in Waltham Abbey. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest dormant accounts cover the period ending 28 February 2025, showing net assets of £100. Net assets were unchanged on the prior period.
By net assets it sits in the upper half of 86 comparable companies in Greater London (median £100, upper quartile £35k).
Ownership and control
- Mr Zulfiqar Ali Khan
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 9 February 20188 yrs ago
- Next accounts due
- 28 November 2026in 35 days
- Confirmation statement due
- 23 February 2027in 122 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 47990
- Other retail sale not in stores, stalls or markets
- SIC 86900
- Other human health activities
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £100 | — | — | — | — | — | — |
| 28 February 2024 | £100 | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £100 at 28 February 2025
- Incorporated five or more years agoIncorporated 9 February 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 122 days
- Next accounts duein 35 days
- Accounts period endNet assets £100 · dormant accounts
- Accounts period endNet assets £100 · dormant accounts
- Incorporated
Similar companies in Greater London
- SOLAR GROW GLOBAL LIMITEDLeatherhead · inc. Feb 2018
- ACME UK INC LIMITEDChertsey · inc. Feb 2018
- LIPCOTE & CO LIMITEDIlford · inc. Nov 2017
- STRIDES GLOBAL CONSUMER HEALTHCARE LIMITEDWatford · inc. Aug 2018
- A-RICH NUTRITION LTDCroydon · inc. Sept 2018
- SAVOO CARE LIMITEDSouthall · inc. Oct 2018
All companies incorporated on 9 February 2018 · in Feb 2018.
Reminders for HERMES PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.